Clinical Trial Update: Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of CFZ533 in pediatric and young adult patients with Type 1 Diabetes Mellitus has completed enrollment, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CFZ533

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2025-01-17